|
|
|
16.09.26 - 14:30
|
China′s AI chip stocks face crucial test as MetaX lock-up period expires (SCMP)
|
|
|
China is bracing for a potential massive sell-off of a high-profile artificial intelligence chip stock on Thursday, when a lock-up period affecting 14 million shares in MetaX Integrated Circuits is set to expire.
Analysts expect MetaX to face “significant selling pressure” when the restricted shares are released for trading, after the expiry of a similar lock-up period for shares in fellow AI chip firm Moore Threads last week sparked an avalanche of sales that wiped nearly 49 billion yuan......
|
|
|
|
|
|
|
|
|
|
|
|
|
16.09.26 - 03:30
|
China Stock Market Poised To Open Under Pressure (AFX)
|
|
|
BEIJING (dpa-AFX) - The China stock market has moved lower in four straight sessions, slumping more than 85 points or 2.3 percent in that span. The Shanghai Composite Index now sits just above the......
|
|
|
|
|
|
|
|
|
15.09.26 - 09:27
|
Aktien Asien: Leichte Verluste bei abwartendem Geschäft (DPA-AFX)
|
|
|
SEOUL/TOKIO/HONGKONG/SHANGHAI (dpa-AFX) - Die asiatischen Aktienmärkte haben am Dienstag mehrheitlich verloren. Dabei blieben die Veränderungen aber überschaubar.Das Geschäft präsentierte sich abwartend. "Vor der mit Spannung erwarteten ......
|
|
|
15.09.26 - 09:24
|
China′s Biotech Stocks Emerging As Latest Ai Trade (ZeroHedge)
|
|
|
China's Biotech Stocks Emerging As Latest Ai Trade
By Charlie Zhu, Bloomberg Markets live reporter and strategist
China's biotech stocks are emerging as the latest AI trade, fueled by expectations the technology will accelerate drug development and boost returns.
The Hang Seng Biotech Index has risen nearly 22% this quarter, set to outperform the Hang Seng Tech gauge by the most on record in Bloomberg data going back to 2015, as investors bet artificial intelligence will reduce timelines and cost in pharmaceutical research and development. The prospect of AI-originated drugs generating licensing and royalty income in the longer run may give the rally staying power.
“AI-driven drug discovery (AIDD) is taking off in China and generating a lot of investor interest, owing to the speed and cost benefits that AI brings,” Citigroup Inc. analysts including John Yung wrote in a note this month. The sector's low penetration of the projected $313 billion global pharmaceutical R&D market impl...
|
|
|
|
|
|
|
15.09.26 - 03:31
|
Losing Streak May Continue For China Stock Market (AFX)
|
|
|
BEIJING (dpa-AFX) - The China stock market has moved lower in three straight sessions, slumping more than 65 points or 1.7 percent in that span. The Shanghai Composite Index now sits just above th......
|
|
|
|
|
14.09.26 - 03:30
|
China Stock Market May Reclaim 3,900-Point Level (AFX)
|
|
|
BEIJING (dpa-AFX) - The China stock market has finished lower in back-to-back sessions, contracting more than 60 points or 1.5 percent in that span. The Shanghai Composite Index now sits just bene......
|
|
|
|
|
|
|
11.09.26 - 10:00
|
Hang Seng rolls out five wealth management strategies (SCMP)
|
|
|
[The content of this article has been produced by our advertising partner.]
Hong Kong's wealth landscape has evolved well beyond single-product investing, with more families now taking an integrated approach to planning that strengthens financial resilience, supports lifestyle continuity and enables long-term stewardship across generations. Hang Seng Bank is leaning into that shift by rolling out five wealth strategies: optimising the service network; shifting focus to family wealth planning;......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
